Developer docs
API playgroundTry for free, no card

Search company profiles

Cromos Pharma

Full company profile

uuid000a4za

Namestring
Cromos Pharma
Legal namestring
Cromos Pharma
Company typeenum
Private
Founded yearint
2004
Descriptiontext

Cromos Pharma is a US-based, privately held contract research organization (CRO) founded in 2004 by Dr. Vlad Bogin. The company delivers fully integrated clinical research services across all trial phases to pharmaceutical, biotechnology, medical device, and academic sponsors, operating from a US headquarters in Dallas, Texas and a European headquarters in Dublin, Ireland. Service lines span project management and monitoring, patient recruitment and retention, regulatory and EU legal representation, medical writing, biostatistics and data management, clinical trial material (CTM) logistics under ISO 9001:2015 and GDP compliance, pharmacovigilance, and independent GCP audits. The company executes trials across 25+ operating countries with explicit regional specialization in Central and Eastern Europe, Central Asia, and Türkiye, claiming 450+ clinical trials conducted in 70+ indications and 150,000+ patients enrolled across 3,500 trial sites.

The commercial model is professional-services based, delivered through direct enterprise sales with dedicated Business Development Directors and country-level leadership across five Eastern European geographies. Notable commercial and technical differentiators include a trademarked 'No Patients – No Payment™' risk-sharing program that bills sponsors only for enrolled patients, a patented warehouse database program for CTM logistics, a Free Multicountry Feasibility Report used as lead-generation, a CPR (Capability-Plan-Rescue) program for at-risk studies, and a recently launched AI-Powered Clinical Trial Budget Calculator that generates cost estimates from protocol concept in minutes. The company markets itself primarily through content (50+-edition Clinical Research Focus newsletter, blog), conference participation (ASCO, BIO, J.P. Morgan Healthcare Conference, SCOPE, AACR), webinars on EU CTR/CTIS, and a multi-language website.

The business is independently owned with no disclosed outside investors, no parent entity, no subsidiaries, no public listing, and no M&A activity on record. Headcount is in the 101–250 range with reportedly 95% of clinical research professionals holding MDs or PhDs. Revenue, funding, and contract-level financials are not publicly disclosed, leaving the company's absolute scale and growth rates inferable only from operational metrics and CRO industry benchmarks.

Short descriptiontext

Cromos Pharma is a US-headquartered, privately held international CRO founded in 2004 that delivers integrated clinical trial services — including patient recruitment, regulatory affairs, data management, medical writing, and CTM logistics — to pharmaceutical, biotech, and medical device sponsors across 25+ countries, with regional specialization in Central and Eastern Europe, Central Asia, and Türkiye.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersDallas, United States
HQ citystring
Dallas
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical research services, contract research organization, patient recruitment services, regulatory support services, clinical trial management
Industry5 codes
PRIMARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYHLAGAAAI
Patient Recruitment, Site Feasibility & Trial Enablement CROs
SECONDARYHLAGAAAG
Medical Writing & Regulatory Submission Support CROs
SECONDARYHLAGAAAH
Pharmacovigilance, Risk Management & Medical Affairs CROs
SECONDARYHLAGAAAF
Clinical Data Management, Biostatistics & Statistical Programming CROs
NAICS code1 code
  • Scientific Research and Development Services5417
SIC code1 code
  • Services-Management Consulting Services8742
Product category
Contract Research Organization (CRO) Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model7 records
1Clinical Research Services
TypeProfessional Services
Description

Full-service CRO providing integrated clinical research solutions including project management, monitoring services, and clinical research services across all trial phases.

cromospharma.com
2Regulatory Services
TypeProfessional Services
Description

Regulatory support including compilation of initial documents, review of IC documentation, obtaining trial subject insurance, secure import/export licenses, and regulatory submissions.

cromospharma.com
3Patient Recruitment Services
TypeProfessional Services
Description

Patient recruitment and retention services with promotional and educational materials, DTC outreach, and investigator materials.

cromospharma.com
4Data Management and Biostatistics
TypeProfessional Services
Description

Comprehensive data management including CRF development, database design, double data entry, SAS programming, and data transfers.

cromospharma.com
5Medical Writing
TypeProfessional Services
Description

Medical writing services including study protocols, investigator brochures, patient informed consent forms, and clinical study reports.

cromospharma.com
6CTM Logistics
TypeProfessional Services
Description

Clinical trial material logistics including warehousing, storage, 24/7 receipt of IMP and CTM, with compliance to ISO 9001:2015 and GDP.

cromospharma.com
7Pharmacovigilance Support
TypeProfessional Services
Description

PV support with therapeutic excellence, QPPV team for EU registered products, and tailored safety solutions.

cromospharma.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Supply Chain
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Cromos Pharma is a US-based, ISO-accredited international Contract Research Organization (CRO) providing integrated clinical research services across all trial phases for pharmaceutical, biotech, and medical device sponsors. Its service portfolio spans patient recruitment and retention, regulatory support, EU legal representation, medical writing, biostatistics and data management, clinical trial material (CTM) logistics, pharmacovigilance, and independent audits. The company differentiates commercially through its trademarked "No Patients – No Payment™" risk-sharing program and operationally through an AI-Powered Clinical Trial Budget Calculator and a patented CTM warehouse database program.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 450+ clinical trials conducted in 70+ indications
+2 more records
Product overview1 text field

Cromos Pharma is a US-based, ISO-accredited international Contract Research Organization (CRO) delivering fully integrated clinical research solutions across all trial phases. The company's portfolio centers on its core Clinical Trial Budget Calculator—an AI-powered tool for cost estimation—alongside comprehensive service modules including Patient Recruitment and Retention, Clinical Research Services, Regulatory Support, EU Legal Representation, Medical Writing, Biostatistics and Data Management, CTM Logistics, Pharmacovigilance Support, and Independent Audits. A key differentiator is the 'No Patients – No Payment™' risk-sharing program. The platform operates across 25+ countries with expertise in Central and Eastern Europe, Central Asia, and Türkiye, having conducted 450+ clinical trials enrolling 150,000+ patients across 3,500 trial sites.

Product and service12 records
1Clinical Research Services
2Patient Recruitment and Retention Services
CategoryPatient recruitment and retention
Description

Comprehensive patient recruitment and retention services including promotional and educational materials, direct-to-consumer outreach, investigator's materials, booster visits, referral sites, and patient commitment programs.

3Regulatory Support Services
CategoryRegulatory affairs
Description

Regulatory services including compilation of initial documents for Regulatory Authorities and ECs/IRBs, IC documentation review, trial subject insurance, import/export licenses, regulatory strategy, and agency submissions.

4EU Legal Representation Services
CategoryRegulatory affairs / EU compliance
Description

Legal gateway to Europe providing legal representation in EU/EEA, QP statement obtainment, and cost-effective regulatory compliance services for sponsors without a local EU entity.

5Medical Writing Services
CategoryMedical writing
Description

Medical writing deliverables including study concepts, clinical study protocols and amendments, statistical analysis plans, Investigator Brochures, IMP Dossiers, Patient Informed Consent Forms, Clinical Study Reports, and publication materials.

6Biostatistics and Data Management Services
CategoryData management and biostatistics
Description

Data management and biostatistics services including CRF development and validation, database design, double data entry, SAS programming, data validation, and data transfers.

7CTM Logistics Services
CategoryClinical trial material logistics
Description

Full-scope clinical trial material logistics including controlled access storage, 24/7 receipt of IMP and CTM, a patented warehouse database program, and GDP- and ISO 9001:2015-compliant distribution.

8Pharmacovigilance (PV) Support Services
CategoryPharmacovigilance
Description

Pharmacovigilance support with therapeutic, technical, and operational excellence, including tailored safety solutions, a QPPV team for EU-registered products, regulatory compliance, and pharmacovigilance consultancy.

9Independent Audits Services
CategoryQuality assurance and auditing
Description

Independent audit services including clinical site GCP audits, documentary Trial Master File audits, system vendor audits, and regulatory inspection readiness support.

10Rescue and Turnaround Services
CategoryRescue / turnaround CRO services
Description

Rescue and turnaround services providing comprehensive recovery plans for studies behind schedule or encountering patient recruitment difficulties, ensuring investments yield return and studies meet timelines.

11Clinical Trial Budget Calculator
CategoryAI-powered planning tool
Description

AI-powered tool developed by Cromos Pharma's expert team that enables sponsors to estimate clinical trial costs, moving from protocol concept to cost clarity in minutes.

12No Patients – No Payment™ Program
CategoryRisk-sharing commercial program
Description

Trademarked risk-sharing program where sponsors pay only for enrolled patients and not for dormant, non-recruiting sites, aligning Cromos Pharma's incentives with sponsor enrollment success.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Mid-sized, science-focused clinical CRO offering full-service Phase I-IV trial management for pharma and biotech — the closest publicly-traded analog to Cromos Pharma's full-service, scientifically-deep operating model.

TypeDirect peer
Description

Mid-market CRO focused on complex therapeutic areas in Phase II-IV trials with strong biometrics and patient recruitment — directly comparable to Cromos's full-service offering and CEE/biotech client profile.

TypeBroad incumbent
Description

Largest global CRO/clinical technology provider combining clinical operations with real-world data and analytics; competes for enterprise CRO contracts as a broad portfolio incumbent.

TypeDirect peer
Description

Specialty mid-size CRO with particular strength in oncology, rare disease, and pediatric trials; closely matches Cromos's therapeutic-area focus and biotech sponsor concentration.

TypeBroad incumbent
Description

Global top-5 CRO with full-service clinical trial management, post-2021 expansion via PRA acquisition — competes for the same enterprise CRO mandates as Cromos at much larger scale.

TypeDirect peer
Description

Mid-tier clinical CRO providing full-service trial management for biotech and pharma sponsors, similar in scale to Cromos with overlapping therapeutic-area and patient recruitment capabilities.

TypeDirect peer
Description

Mid-sized, science-driven CRO with full-service clinical operations and biometrics for small/mid-cap biopharma — directly comparable in scale, scientific talent emphasis, and service breadth.

8Clinart
TypeRegional player
Description

Eastern European CRO with regional hubs and global trial experience; competes head-to-head with Cromos for CEE-rooted studies and biotech sponsors targeting European patient access.

TypeRegional player
Description

CRO historically focused on Central and Eastern Europe with multi-country trial execution; the most direct geographic competitor to Cromos in its core CEE operating footprint.

TypeDirect peer
Description

Mid-size tech-enabled CRO with global operational reach in oncology, cardiovascular, and rare disease; positioned similarly to Cromos for biotech sponsors and adaptive trial designs.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability7 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Cromos Pharma

Contract Research Organization (CRO) Servicescromospharma.com

Cromos Pharma is a US-headquartered, privately held international CRO founded in 2004 that delivers integrated clinical trial services — including patient recruitment, regulatory affairs, data management, medical writing, and CTM logistics — to pharmaceutical, biotech, and medical device sponsors across 25+ countries, with regional specialization in Central and Eastern Europe, Central Asia, and Türkiye.

What Cromos Pharma does

Cromos Pharma is a US-based, privately held contract research organization (CRO) founded in 2004 by Dr. Vlad Bogin. The company delivers fully integrated clinical research services across all trial phases to pharmaceutical, biotechnology, medical device, and academic sponsors, operating from a US headquarters in Dallas, Texas and a European headquarters in Dublin, Ireland. Service lines span project management and monitoring, patient recruitment and retention, regulatory and EU legal representation, medical writing, biostatistics and data management, clinical trial material (CTM) logistics under ISO 9001:2015 and GDP compliance, pharmacovigilance, and independent GCP audits. The company executes trials across 25+ operating countries with explicit regional specialization in Central and Eastern Europe, Central Asia, and Türkiye, claiming 450+ clinical trials conducted in 70+ indications and 150,000+ patients enrolled across 3,500 trial sites.

The commercial model is professional-services based, delivered through direct enterprise sales with dedicated Business Development Directors and country-level leadership across five Eastern European geographies. Notable commercial and technical differentiators include a trademarked 'No Patients – No Payment™' risk-sharing program that bills sponsors only for enrolled patients, a patented warehouse database program for CTM logistics, a Free Multicountry Feasibility Report used as lead-generation, a CPR (Capability-Plan-Rescue) program for at-risk studies, and a recently launched AI-Powered Clinical Trial Budget Calculator that generates cost estimates from protocol concept in minutes. The company markets itself primarily through content (50+-edition Clinical Research Focus newsletter, blog), conference participation (ASCO, BIO, J.P. Morgan Healthcare Conference, SCOPE, AACR), webinars on EU CTR/CTIS, and a multi-language website.

The business is independently owned with no disclosed outside investors, no parent entity, no subsidiaries, no public listing, and no M&A activity on record. Headcount is in the 101–250 range with reportedly 95% of clinical research professionals holding MDs or PhDs. Revenue, funding, and contract-level financials are not publicly disclosed, leaving the company's absolute scale and growth rates inferable only from operational metrics and CRO industry benchmarks.

Cromos Pharma firmographics

Firmographics
Name
Cromos Pharma
Legal name
Cromos Pharma
Website
https://cromospharma.com
Company type
Private
Founded year
2004
Operating status
Operating
Headcount range
101–250 employees
Short description
Cromos Pharma is a US-headquartered, privately held international CRO founded in 2004 that delivers integrated clinical trial services — including patient recruitment, regulatory affairs, data management, medical writing, and CTM logistics — to pharmaceutical, biotech, and medical device sponsors across 25+ countries, with regional specialization in Central and Eastern Europe, Central Asia, and Türkiye.
Ownership category
akta.pro rank

Cromos Pharma industry classification

Industry
Product category
Contract Research Organization (CRO) Services
NAICS
Scientific Research and Development Services (5417)
SIC
Services-Management Consulting Services (8742)
akta.pro industry
PRIMARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYHLAGAAAI
Patient Recruitment, Site Feasibility & Trial Enablement CROs
SECONDARYHLAGAAAG
Medical Writing & Regulatory Submission Support CROs
SECONDARYHLAGAAAH
Pharmacovigilance, Risk Management & Medical Affairs CROs
SECONDARYHLAGAAAF
Clinical Data Management, Biostatistics & Statistical Programming CROs

Keywords

  • Clinical research services
  • Contract research organization
  • Patient recruitment services
  • Regulatory support services
  • Clinical trial management

Where Cromos Pharma is headquartered

Location

Headquarters

HQ city
Dallas
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Cromos Pharma business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Supply Chain

Revenue model

  1. Clinical Research Services: Full-service CRO providing integrated clinical research solutions including project management, monitoring services, and clinical research services across all trial phases.
  2. Regulatory Services: Regulatory support including compilation of initial documents, review of IC documentation, obtaining trial subject insurance, secure import/export licenses, and regulatory submissions.
  3. Patient Recruitment Services: Patient recruitment and retention services with promotional and educational materials, DTC outreach, and investigator materials.
  4. Data Management and Biostatistics: Comprehensive data management including CRF development, database design, double data entry, SAS programming, and data transfers.
  5. Medical Writing: Medical writing services including study protocols, investigator brochures, patient informed consent forms, and clinical study reports.
  6. CTM Logistics: Clinical trial material logistics including warehousing, storage, 24/7 receipt of IMP and CTM, with compliance to ISO 9001:2015 and GDP.
  7. Pharmacovigilance Support: PV support with therapeutic excellence, QPPV team for EU registered products, and tailored safety solutions.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Cromos Pharma product offering

Product offering

Core offering

Cromos Pharma is a US-based, ISO-accredited international Contract Research Organization (CRO) providing integrated clinical research services across all trial phases for pharmaceutical, biotech, and medical device sponsors. Its service portfolio spans patient recruitment and retention, regulatory support, EU legal representation, medical writing, biostatistics and data management, clinical trial material (CTM) logistics, pharmacovigilance, and independent audits. The company differentiates commercially through its trademarked "No Patients – No Payment™" risk-sharing program and operationally through an AI-Powered Clinical Trial Budget Calculator and a patented CTM warehouse database program.

Product overview

Cromos Pharma is a US-based, ISO-accredited international Contract Research Organization (CRO) delivering fully integrated clinical research solutions across all trial phases. The company's portfolio centers on its core Clinical Trial Budget Calculator—an AI-powered tool for cost estimation—alongside comprehensive service modules including Patient Recruitment and Retention, Clinical Research Services, Regulatory Support, EU Legal Representation, Medical Writing, Biostatistics and Data Management, CTM Logistics, Pharmacovigilance Support, and Independent Audits. A key differentiator is the 'No Patients – No Payment™' risk-sharing program. The platform operates across 25+ countries with expertise in Central and Eastern Europe, Central Asia, and Türkiye, having conducted 450+ clinical trials enrolling 150,000+ patients across 3,500 trial sites.

Differentiator

Problem solved

Functional benefit

Products and services

  • Clinical Research Services
  • Patient Recruitment and Retention Services Comprehensive patient recruitment and retention services including promotional and educational materials, direct-to-consumer outreach, investigator's materials, booster visits, referral sites, and patient commitment programs.
  • Regulatory Support Services Regulatory services including compilation of initial documents for Regulatory Authorities and ECs/IRBs, IC documentation review, trial subject insurance, import/export licenses, regulatory strategy, and agency submissions.
  • EU Legal Representation Services Legal gateway to Europe providing legal representation in EU/EEA, QP statement obtainment, and cost-effective regulatory compliance services for sponsors without a local EU entity.
  • Medical Writing Services Medical writing deliverables including study concepts, clinical study protocols and amendments, statistical analysis plans, Investigator Brochures, IMP Dossiers, Patient Informed Consent Forms, Clinical Study Reports, and publication materials.
  • Biostatistics and Data Management Services Data management and biostatistics services including CRF development and validation, database design, double data entry, SAS programming, data validation, and data transfers.
  • CTM Logistics Services Full-scope clinical trial material logistics including controlled access storage, 24/7 receipt of IMP and CTM, a patented warehouse database program, and GDP- and ISO 9001:2015-compliant distribution.
  • Pharmacovigilance (PV) Support Services Pharmacovigilance support with therapeutic, technical, and operational excellence, including tailored safety solutions, a QPPV team for EU-registered products, regulatory compliance, and pharmacovigilance consultancy.
  • Independent Audits Services Independent audit services including clinical site GCP audits, documentary Trial Master File audits, system vendor audits, and regulatory inspection readiness support.
  • Rescue and Turnaround Services Rescue and turnaround services providing comprehensive recovery plans for studies behind schedule or encountering patient recruitment difficulties, ensuring investments yield return and studies meet timelines.
  • Clinical Trial Budget Calculator AI-powered tool developed by Cromos Pharma's expert team that enables sponsors to estimate clinical trial costs, moving from protocol concept to cost clarity in minutes.
  • No Patients – No Payment™ Program Trademarked risk-sharing program where sponsors pay only for enrolled patients and not for dormant, non-recruiting sites, aligning Cromos Pharma's incentives with sponsor enrollment success.

Quantifiable outcome

  • 450+ clinical trials conducted in 70+ indications
  • +2 more outcomes

Companies that use Cromos Pharma

Customer profile

Segments4 records

Ideal customer profiles4 records

Cromos Pharma technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature4 records

Cromos Pharma partnerships and signals

Strategic signal

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Cromos Pharma competitors and assessment

Company assessment

Direct peers

  • Medpace Holdings: Mid-sized, science-focused clinical CRO offering full-service Phase I-IV trial management for pharma and biotech — the closest publicly-traded analog to Cromos Pharma's full-service, scientifically-deep operating model.
  • Worldwide Clinical Trials: Mid-market CRO focused on complex therapeutic areas in Phase II-IV trials with strong biometrics and patient recruitment — directly comparable to Cromos's full-service offering and CEE/biotech client profile.
  • Premier Research: Specialty mid-size CRO with particular strength in oncology, rare disease, and pediatric trials; closely matches Cromos's therapeutic-area focus and biotech sponsor concentration.
  • Advanced Clinical: Mid-tier clinical CRO providing full-service trial management for biotech and pharma sponsors, similar in scale to Cromos with overlapping therapeutic-area and patient recruitment capabilities.
  • Rho: Mid-sized, science-driven CRO with full-service clinical operations and biometrics for small/mid-cap biopharma — directly comparable in scale, scientific talent emphasis, and service breadth.
  • Clinipace Worldwide: Mid-size tech-enabled CRO with global operational reach in oncology, cardiovascular, and rare disease; positioned similarly to Cromos for biotech sponsors and adaptive trial designs.

Broad incumbents

  • IQVIA: Largest global CRO/clinical technology provider combining clinical operations with real-world data and analytics; competes for enterprise CRO contracts as a broad portfolio incumbent.
  • ICON plc: Global top-5 CRO with full-service clinical trial management, post-2021 expansion via PRA acquisition — competes for the same enterprise CRO mandates as Cromos at much larger scale.

Regional players

  • Clinart: Eastern European CRO with regional hubs and global trial experience; competes head-to-head with Cromos for CEE-rooted studies and biotech sponsors targeting European patient access.
  • OCT Clinical: CRO historically focused on Central and Eastern Europe with multi-country trial execution; the most direct geographic competitor to Cromos in its core CEE operating footprint.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Cromos Pharma social profiles

Digital presence

Cromos Pharma compliance and trust

Trust signal

Compliance2 records

Cromos Pharma financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Cromos Pharma leadership team

Management profile

Number of profiles

Profiles9 records

Cromos Pharma funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Cromos Pharma M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cromos Pharma

What does Cromos Pharma do?

Cromos Pharma is a US-based, ISO-accredited international Contract Research Organization (CRO) providing integrated clinical research services across all trial phases for pharmaceutical, biotech, and medical device sponsors. Its service portfolio spans patient recruitment and retention, regulatory support, EU legal representation, medical writing, biostatistics and data management, clinical trial material (CTM) logistics, pharmacovigilance, and independent audits. The company differentiates commercially through its trademarked "No Patients – No Payment™" risk-sharing program and operationally through an AI-Powered Clinical Trial Budget Calculator and a patented CTM warehouse database program.

Is Cromos Pharma a public or private company?

Cromos Pharma is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Cromos Pharma founded?

Cromos Pharma was founded in 2004. It employs 101 to 250 people.

Where is Cromos Pharma based?

Cromos Pharma is headquartered in Dallas, United States, in the North America region.

How does Cromos Pharma make money?

Seven revenue lines are on record. Clinical Research Services are the primary driver. The others are regulatory Services, patient Recruitment Services, data Management and Biostatistics, medical Writing, CTM Logistics and pharmacovigilance Support.

Who are Cromos Pharma's main competitors?

Direct peers on record are Medpace Holdings, Worldwide Clinical Trials, Premier Research, Advanced Clinical, Rho and Clinipace Worldwide. Broad incumbents are IQVIA and ICON plc. Regional players are Clinart and OCT Clinical.

Does Cromos Pharma have an API?

No public API is recorded for Cromos Pharma.

What industry is Cromos Pharma in?

Cromos Pharma's product category is Contract Research Organization (CRO) Services. Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAGAAAI, Patient Recruitment, Site Feasibility & Trial Enablement CROs. Its NAICS code is 5417 and its SIC code is 8742.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
CromospharmaRegulatory Pathways for Rare Disease Drug DevelopmentThis article provides an informational overview of regulatory pathways available for rare and ultra-rare disease drug development in the US and Europe, including Orphan Drug Designation, FDA's START Pilot Program, Fast Track, Breakthrough Therapy, Accelerated Approval, and EMA's PRIME program. It highlights that over 440 million people worldwide are affected by rare diseases and that over 1,430 clinical trials have been conducted since 2020, with significant focus on conditions like Cystic Fibrosis, Spinal Muscular Atrophy, and Hemophilia A. The piece, published on Rare Disease Day 2025, also promotes Cromos Pharma's services in navigating these regulatory frameworks and facilitating patient recruitment for clinical trials.CromospharmaAI in Clinical Trials: 8 Groundbreaking Innovations That Defined the YearA promotional piece from Cromos Pharma outlines eight AI-driven innovations in clinical trials, including Unlearn.AI's digital twins, Insilico Medicine's 30-month IPF drug discovery, Mass General Brigham's RECTIFIER screening tool, and Protocol AI. It cites figures such as 97.9% to 100% accuracy for RECTIFIER, 35% cost and time reductions for Protocol AI, and doubled recruitment rates for Trial Pathfinder.SofpromedList of CROs for Clinical Trials in the United StatesA promotional listing presents 20 clinical research organizations operating in the United States, offering services such as regulatory affairs, site management, monitoring, data management, biostatistics, pharmacovigilance and medical writing. Entries include Sofpromed, ProTrials, Cromos Pharma, Emmes, Theradex and others, with details on founding dates, therapeutic focus and service scope.PR NewswireNRx Pharmaceuticals to Lead Development of COVID-19 Medicines and Vaccines in Central Europe and the Caucasus Region in Collaboration with the Lugar Institute and Cromos PharmaNRx Pharmaceuticals announced a master services agreement with Cromos Pharma to conduct Phase III clinical trials of ZYESAMI (Aviptadil acetate) for COVID-19 treatment across Central Europe and the Caucasus Region in collaboration with the Senator Richard Lugar Research Institute. The approximately $60 million trial costs will be shared by NRx and Denk Pharma, with Ministries of Health of Georgia, Hungary, and Ukraine overseeing regional operations. NRx aims to complete its inhaled drug trial by September 2021 and seek Emergency Use Authorization from regional regulators for treatment of critically-ill COVID-19 patients suffering respiratory failure.GlobeNewswireEuro-Australian collaboration offers scalable solutions for biotech: announced at Bio-Europe 2020Avance Clinical and Cromos Pharma announced a collaboration to let biotechs run pre-IND studies in Australia and expand to Central/Eastern Europe for Phase 2-3 trials. The model lets biotechs keep data and trial management in Australia while accessing Cromos's 2,500 sites, with Australia's 43.5% tax rebate on clinical costs.GlobeNewswireCromos Pharma Supports R-Pharm in Initiation of a Global Program to Test Two of its Leading Candidates in Patients with Severe COVID-19 Infection. First Patients Have Been RecruitedR-Pharm and Cromos Pharma randomized the first patients into a trial evaluating Olokizumab and RPH-104 in severe COVID-19. The multi-center, double-blind Phase 2/3 trial will recruit about 180 patients across 20 sites, with results guiding a larger Phase 3. The trial aims to assess whether cytokine blockade can improve outcomes.GlobeNewswireStephanie Finnegan joins Cromos™ Pharma as Chief Operating Officer, company looks to expand its North American footprintStephanie Finnegan was appointed chief operating officer of Cromos Pharma, joining the US office to oversee European and US operations. She brings nearly three decades of biopharmaceutical experience, including leading a US-based CRO into the global market. The company plans to leverage her knowledge to expand its North American footprint.GlobeNewswireCromos(TM) Pharma Opens a Representative Office in HungaryCromos Pharma opened a representative office in Budapest, Hungary, on Jan 11, 2016. CEO Vlad Bogin cited Hungary's 10 million population and medical standards as a prime location, and the move follows expansion to the Czech Republic. The company aims to expand its geographic presence in Central and Eastern Europe.GlobeNewswireDr. Tsira Jibladze Appointed Cromos(TM) Pharma's Country Head for GeorgiaCromos Pharma appointed Dr. Tsira Jibladze as Country Head for Georgia. She holds an MD in Cardiology and MPH, and previously led Tbilisi's Red Cross branch and the Ministry of Health. She aims to bring the company's operations to new heights.